Tempest Therapeutics (TPST) Change in Acquisitions & Divestments (2013 - 2019)

Tempest Therapeutics has reported Change in Acquisitions & Divestments for 7 years, with the latest figure at $1.4 million in Q2 2019.

• Quarterly Change in Acquisitions & Divestments fell 93.02% year-over-year to $1.4 million in Q2 2019, while the trailing twelve-month figure through Mar 2020 was $1.4 million (up 105.9% YoY) and the FY2019 annual result came in at $4.4 million, up 75.96% from the prior year.
• Change in Acquisitions & Divestments declined to $1.4 million in Q2 2019 per TPST's latest filing, from $3.0 million in the prior quarter.
• Over five years, Change in Acquisitions & Divestments peaked at $87.8 million in Q4 2017 and troughed at -$68.3 million in Q4 2018.
• A 5-year average of $10.7 million and a median of $19.5 million in 2015 frame the typical range for Change in Acquisitions & Divestments.
• The sharpest annual moves came in 2015 and 2017: Change in Acquisitions & Divestments surged 700.92% in 2015, then tumbled 1125.27% in 2017.
• Over 5 years, Change in Acquisitions & Divestments stood at $50.4 million in 2015, then plunged by 143.48% to -$21.9 million in 2016, then soared by 500.52% to $87.8 million in 2017, then slumped by 177.76% to -$68.3 million in 2018, then surged by 102.05% to $1.4 million in 2019.
• According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $1.4 million, $3.0 million, and -$68.3 million for Q2 2019, Q1 2019, and Q4 2018 respectively.